Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Hepatology International|July 15, 2020
Novel systemic therapy for hepatocellular carcinomaYawen Dong, Tsung-Hao Liu, Thomas Yau, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|April 11, 2022
Immune checkpoint inhibitors for hepatocellular carcinoma - A game changer in treatment landscapeTsung-Hao Liu, Ying-Chun Shen, Ann-Lii ChengJournal of Gastroenterology and Hepatology|February 11, 2016
Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinomaYu-Yun Shao, Tsung-Hao Liu, Ying-Hui Lee, et al.Clinical and Molecular Hepatology|January 30, 2023
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspectiveTung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, et al.Journal of Hepatology|November 17, 2009
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivationKuen-Feng Chen, Hui-Chuan Yu, Tsung-Hao Liu, et al.International Journal of Molecular Sciences|December 10, 2021
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular CarcinomaChing-Tso Chen, Tsung-Hao Liu, Yu-Yun Shao, et al.Scientific Reports|July 3, 2019
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort studyMeng-Rui Lee, Kai-Lun Yu, Hung-Yang Kuo, et al.JCO Precision Oncology|December 10, 2025
Expression of Poliovirus Receptor, the Ligand of TIGIT, Associated With Immune-Cold Tumor Microenvironment in Hepatocellular CarcinomaLi-Chun Lu, Yi-Hsuan Lee, Yu-Yun Shao, et al.Expert Review of Gastroenterology & Hepatology|May 29, 2019
Considerations of heterogeneity in clinical trials for hepatocellular carcinomaTsung-Hao Liu, Yu-Yun Shao, Li-Chun Lu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2019
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinomaYu-Yun Shao, Tsung-Hao Liu, Chiun Hsu, et al.Pageof 3